KR102279283B9 - 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물 - Google Patents

락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물

Info

Publication number
KR102279283B9
KR102279283B9 KR1020190127343A KR20190127343A KR102279283B9 KR 102279283 B9 KR102279283 B9 KR 102279283B9 KR 1020190127343 A KR1020190127343 A KR 1020190127343A KR 20190127343 A KR20190127343 A KR 20190127343A KR 102279283 B9 KR102279283 B9 KR 102279283B9
Authority
KR
South Korea
Prior art keywords
composition
lactobacillus helveticus
bifidobacterium species
treating nafld
alleviating
Prior art date
Application number
KR1020190127343A
Other languages
English (en)
Other versions
KR20210044369A (ko
KR102279283B1 (ko
Inventor
정현채
김병국
최인석
허보혜
서민호
김우리
석기태
윤기수
신민재
윤상준
Original Assignee
주식회사 종근당바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=75537840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102279283(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 주식회사 종근당바이오 filed Critical 주식회사 종근당바이오
Priority to KR1020190127343A priority Critical patent/KR102279283B1/ko
Priority to PCT/KR2020/007627 priority patent/WO2021075663A1/ko
Publication of KR20210044369A publication Critical patent/KR20210044369A/ko
Application granted granted Critical
Publication of KR102279283B1 publication Critical patent/KR102279283B1/ko
Publication of KR102279283B9 publication Critical patent/KR102279283B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020190127343A 2019-10-14 2019-10-14 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물 KR102279283B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020190127343A KR102279283B1 (ko) 2019-10-14 2019-10-14 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물
PCT/KR2020/007627 WO2021075663A1 (ko) 2019-10-14 2020-06-12 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간질환의 예방, 개선, 또는 치료용 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190127343A KR102279283B1 (ko) 2019-10-14 2019-10-14 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
KR20210044369A KR20210044369A (ko) 2021-04-23
KR102279283B1 KR102279283B1 (ko) 2021-07-20
KR102279283B9 true KR102279283B9 (ko) 2022-05-02

Family

ID=75537840

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190127343A KR102279283B1 (ko) 2019-10-14 2019-10-14 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물

Country Status (2)

Country Link
KR (1) KR102279283B1 (ko)
WO (1) WO2021075663A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114145461B (zh) * 2021-11-26 2023-10-31 广州能靓生物技术有限公司 一种缓解非酒精性脂肪肝的益生菌组合物
KR102626672B1 (ko) * 2022-04-29 2024-01-18 한림대학교 산학협력단 락토바실러스 헬베티커스 ckdb001 균주를 포함하는 알코올성 간질환의 예방, 개선, 또는 치료용 조성물
CN116064286B (zh) * 2022-08-19 2023-08-11 浙江大学 具有改善非酒精性肝病的瑞士乳杆菌zjuids11及其应用
KR102578408B1 (ko) * 2022-11-21 2023-09-18 마이크로바이오헬스케어 주식회사 지방간 개선 효능을 갖는 신규 락토바실러스 사케이 균주 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584542B2 (ja) * 1975-06-03 1983-01-26 チッソ株式会社 ソルビンサンノケンダクエキモシクハペ−ストノ セイゾウホウ
JP5804542B2 (ja) * 2010-03-25 2015-11-04 雪印メグミルク株式会社 脂肪肝予防及び／又は抑制剤
US10245288B2 (en) * 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
AU2015258769A1 (en) * 2014-05-12 2016-12-01 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
WO2020041581A1 (en) * 2018-08-23 2020-02-27 Cornell University Methods and compositions for preventing and treating inflammatory bowel disease and nonalcoholic fatty liver disease
KR101955276B1 (ko) 2018-11-19 2019-03-08 주식회사한국야쿠르트 비알코올성 지방간 개선 효능을 갖는 락토바실러스 카제이 hy7207 및 이를 유효성분으로 함유하는 제품

Also Published As

Publication number Publication date
WO2021075663A1 (ko) 2021-04-22
KR20210044369A (ko) 2021-04-23
KR102279283B1 (ko) 2021-07-20

Similar Documents

Publication Publication Date Title
KR102279283B9 (ko) 락토바실러스 헬베티커스 및 비피도박테리움 균주를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물
PL3681470T3 (pl) Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
EP4086336A4 (en) STRAIN OF LACTOBACILLUS PLANTARUM, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES CONTAINING SAME
EP3727405A4 (en) COMPOSITION INCLUDING LACTOBACILLUS PLANTARUM FOR THE PREVENTION AND / OR TREATMENT OF MENTAL DISORDERS
KR102128098B9 (ko) 락토바실러스 델브루키 subsp. 락티스 CKDB001 균주, 및 이를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물
EP3722412A4 (en) NEW BIFIDOBACTERIUM, AND COMPOSITION CONTAINING THIS BACTERIA
IL275626A (en) Preparations and methods for surface treatment
IL254975A0 (en) Recombinant bacterium Lactococcus lactis and preparations containing it
PH12019502341A1 (en) Compositions and methods involving probiotic molecules
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MY194858A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
EP3812452A4 (en) BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
PL3387156T3 (pl) Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych
EP4086334A4 (en) LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES
EP4086335A4 (en) LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME
EP4005579A4 (en) COMPOSITION WITH LACTOBACILLUS REUTERI ATG-F4 FOR THE PREVENTION OR TREATMENT OF MUSCLE DISEASES
EP3787668C0 (en) PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION
IL290348B1 (en) Compositions and methods for surface treatment
ZA202201337B (en) Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium
KR102514149B9 (ko) 락토바실러스 아시도필루스를 포함하는 갱년기 여성의 근관절통, 두통, 또는 질 건조증의 예방, 개선, 또는 치료용 조성물
EP3722413A4 (en) NOVEL BIFIDOBACTERIA AND COMPOSITION WITH NOVEL BIFIDOBACTERIA
IL280348A (en) Preparations and methods for surface treatment
GB201905386D0 (en) Probiotic compositions and uses thereof
EP3620512A4 (en) COMPOSITION OF LACTOBACILLUS PLANTARUM CJLP475 STEM AND LACTOBACILLUS PLANTARUM CJLP17 STEM AND THEIR USES

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J202 Request for trial for correction [limitation]
J301 Trial decision

Free format text: TRIAL NUMBER: 2022105000004; TRIAL DECISION FOR CORRECTION REQUESTED 20220107

Effective date: 20220331